Both companies focus their efforts in totally different fields. Antares is pushing the in-house programs MTX and QST plus the injectors with TEVA (and of course the gel programs and Pfizer deal). None of the above programs compete with injex, which their current focus is the cosmetic market (which also has high competition from many other companies and different solution).
look to me like the other poster is trying to lay the ground for stock promotion in the future, but lack the understanding of the competition, so he keep coming to the ATRS board, where the only common thing is a needle free injector.
(And i know some engine manufacturers who got needle free injectors.... :o))
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.